Search
Pocenbrodib
go.drugbank.com/drugs/DB21616InvestigationalPocenbrodib is under investigation in clinical trial NCT06785636 (Open-Label Study of Pocenbrodib Alone and in Combination With Abiraterone Acetate, Olaparib, or 177Lu-PSMA-617).
Picrotoxin
go.drugbank.com/drugs/DB00466ExperimentalA noncompetitive antagonist at GABA-A receptors and thus a convulsant. Picrotoxin blocks the gamma-aminobutyric acid-activated chloride ionophore. Although it is most often used as a research tool, it has been used as a CNS stimulant and...
Categories: Compounds used in a research, industrial, or household settingRemacemide
go.drugbank.com/drugs/DB06458ExperimentalCategories: Compounds used in a research, industrial, or household settingNitric acid
go.drugbank.com/drugs/DB15995ExperimentalCategories: Compounds used in a research, industrial, or household settingTerbutryn
go.drugbank.com/drugs/DB08215ExperimentalCategories: Compounds used in a research, industrial, or household settingTriacetin
go.drugbank.com/drugs/DB16005InvestigationalCategories: Compounds used in a research, industrial, or household settingEtisulergine
go.drugbank.com/drugs/DB19706ExperimentalEtisulergine is a small molecule drug. Etisulergine has a monoisotopic molecular weight of 376.19 Da.
Categories: Heterocyclic Compounds with 4 or More RingsLergotrile
go.drugbank.com/drugs/DB21016ExperimentalLergotrile is a small molecule drug. Lergotrile has a monoisotopic molecular weight of 299.12 Da.
Categories: Heterocyclic Compounds with 4 or More RingsCytisine
go.drugbank.com/drugs/DB09028InvestigationalAlso known as baptitoxine or sophorine, cytisine has been used as a smoking cessation treatment since 1964, and is relatively unknown in regions outside of central and Eastern Europe.
Bavituximab
go.drugbank.com/drugs/DB05136InvestigationalBavituximab is a chimeric Anti-PS monoclonal antibody analog which is used to potentially treat cancers and viral infections. It binds to phosphatidylserine and other exposed host cell lipids when induced by cellular stress. Additional a...